 |
|
Recombinant anti-D for prevention of maternal-foetal Rh(D) alloimmunization: a randomized multi-centre clinical trial
Rahul Vishwanath Mayekar, Gopalkrishna Vinayak Paradkar, Archana Anilkumar Bhosale, Rekha Sachan, Sumalatha Beeram, Ashok Ramachandra Anand, Shuchita Ramesh Mundle, Yamini Trivedi, Rashmi MD, Kiran Pandharinath Patole, Pradip Wamanrao Sambarey, Gautam Vinod Daftary, James John, Ganesh Harishchandra Divekar
Obstet Gynecol Sci. 2020;63(3):315-322. Published online 2020 Apr 21 DOI: https://doi.org/10.5468/ogs.2020.63.3.315
|
|
Citations to this article as recorded by
 Current Insights Into K-associated Fetal Anemia and Potential Treatment Strategies for Sensitized Pregnancies
Margaret C. Carpenter, Scarlett C. Souter, Ronnie J. Zipkin, Margaret E. Ackerman
Transfusion Medicine Reviews.2024; 38(1): 150779. CrossRef Trogocytosis drives red blood cell antigen loss in association with antibody-mediated immune suppression
Yoelys Cruz-Leal, Peter A. A. Norris, Lazaro Gil Gonzalez, Danielle Marjoram, Hanna Wabnitz, Yuexin Shan, Alan H. Lazarus
Blood.2024; 143(9): 807. CrossRef Internationale richtlijnen voor het gebruik van Rhesus D immunoglobuline: een vergelijkend onderzoek en de plaats van foetale Rhesus D genotypering
Y. Depaepe, N. van Oostrum, E. Roets, K. Roelens
Tijdschrift voor Geneeskunde.2023;[Epub] CrossRef A Real-world Prospective Study to Evaluate the Geographical Distribution, Isoimmunization Rate, and Utilization of Prophylactic Treatment of Rh-negative Pregnant Women in India (RhYTHM Study)
Ashwin Rao, Pratik Shah, Supriya Hiraman Pawar, Shilpa Nandakumar Naik, Tumati Sivjyothi, Ashwin Kakkar
Journal of South Asian Federation of Obstetrics and Gynaecology.2023; 15(5): 594. CrossRef Post-marketing safety evaluation of recombinant anti-rho (D) immunoglobulin for the prevention of maternal rh-isoimmunization: A prospective, multi-centre, phase IV study
Pratik Shah, Sweety Saigal, Shilpa N Naik, Shrinivas Gadappa, Swati Kochar, Lakshmikantha G Lakshmikantha, Sweety Saigal, Ravindra Pukale, Kishma Vinod
Indian Journal of Obstetrics and Gynecology Research.2023; 10(4): 474. CrossRef FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization
Annie Qiu, Anabel Miller, Flavia Dei Zotti, Manjula Santhanakrishnan, Jeanne E. Hendrickson, Maria Tredicine, Sean R. Stowell, Chance John Luckey, James C. Zimring, Krystalyn E. Hudson
Frontiers in Immunology.2022;[Epub] CrossRef Rhesus-D-Alloimmunisierung: R-Anti-D wirksam und sicher in der Anwendung
Transfusionsmedizin - Immunhämatologie · Hämotherapie · Transplantationsimmunologie · Zelltherapie.2020; 10(04): 195. CrossRef
|